Company Filing History:
Years Active: 2022-2025
Title: Innovations by Spyridon Papapetropoulos
Introduction
Spyridon Papapetropoulos is an accomplished inventor based in Wellesley, MA (US). He has made significant contributions to the field of medicine, particularly in the treatment of movement disorders. With a total of 2 patents to his name, his work is recognized for its potential impact on patients suffering from conditions such as essential tremor, epilepsy, and Parkinson's disease.
Latest Patents
One of his latest patents focuses on treating essential tremor using (R)-2-(4-Isopropylphenyl)-N-(1-(5-(2,2,2-Trifluoroethoxy)pyridin-2-yl)ethyl)acetamide. This invention relates to methods and materials for treating mammals that have, or are at risk of developing, one or more movement disorders. The patent includes compositions that feature T-type calcium channel antagonists, such as Cav3 antagonists like CX-8998. These compositions are designed to be administered to mammals to effectively treat movement disorders.
Career Highlights
Spyridon is currently associated with Cavion, Inc., where he continues to innovate and develop new treatments. His work is characterized by a commitment to improving the quality of life for individuals affected by debilitating conditions.
Collaborations
He collaborates with notable colleagues, including Margaret S. Lee and Michelle S. Higgin, who contribute to the research and development efforts at Cavion, Inc.
Conclusion
Spyridon Papapetropoulos exemplifies the spirit of innovation in the medical field, with his patents paving the way for new treatment options for movement disorders. His contributions are vital in the ongoing quest to enhance patient care and outcomes.